Sanofi to Buy Vaccine Company Firm Protein Sciences

French drug company Sanofi SA (SNY) said Tuesday it would buy vaccines biotechnology firm Protein Sciences for an up-front payment of $650 million.

Sanofi said it would pay up to another $100 million if the influenza vaccine specialist achieves certain milestones.

Read more